Category:Experiments

0–9

• The intestinal microflora in allergic Estonian and Swedish 2-year-old children/Experiment 1
• The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects/Experiment 1
• Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients/Experiment 1
• Quantitative differences in intestinal Faecalibacterium prausnitzii in obese Indian children/Experiment 1
• Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome/Experiment 1
• Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults/Experiment 1
• Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns/Experiment 1
• Pyrosequencing study of fecal microflora of autistic and control children/Experiment 1
• Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa/Experiment 1
• Effect of mother's weight on infant's microbiota acquisition, composition, and activity during early infancy: a prospective follow-up study initiated in early pregnancy/Experiment 1
• Disordered microbial communities in the upper respiratory tract of cigarette smokers/Experiment 1
• Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome/Experiment 1
• Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome/Experiment 1
• Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome/Experiment 1
• Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii/Experiment 1
• Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers/Experiment 1
• Linking long-term dietary patterns with gut microbial enterotypes/Experiment 1
• Dynamic gut microbiome across life history of the malaria mosquito Anopheles gambiae in Kenya/Experiment 1
• Genomic analysis identifies association of Fusobacterium with colorectal carcinoma/Experiment 1
• Low diversity of the gut microbiota in infants with atopic eczema/Experiment 1
• Alterations in the gut microbiome of children with severe ulcerative colitis/Experiment 1
• Distinct gut microbiota in southeastern African and northern European infants/Experiment 1
• Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome/Experiment 1
• Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome/Experiment 1
• Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome/Experiment 1
• The microbiota of the gut in preschool children with normal and excessive body weight/Experiment 1
• Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis/Experiment 1
• Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans/Experiment 1
• IBS-associated phylogenetic unbalances of the intestinal microbiota are not reverted by probiotic supplementation/Experiment 1
• Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome/Experiment 1
• Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer/Experiment 1
• Subgingival biodiversity in subjects with uncontrolled type-2 diabetes and chronic periodontitis/Experiment 1
• High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin/Experiment 1
• Alterations in intestinal microbiota of elderly Irish subjects post-antibiotic therapy/Experiment 1
• Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters/Experiment 1
• Gut microbiome composition is linked to whole grain-induced immunological improvements/Experiment 1
• Gut microbiota composition is correlated to grid floor induced stress and behavior in the BALB/c mouse/Experiment 1
• The lung microbiome in moderate and severe chronic obstructive pulmonary disease/Experiment 1
• Microbiome dynamics of human epidermis following skin barrier disruption/Experiment 1
• Modulation of potential respiratory pathogens by pH1N1 viral infection/Experiment 1
• Fusobacterium is associated with colorectal adenomas/Experiment 1
• Microarray analysis reveals marked intestinal microbiota aberrancy in infants having eczema compared to healthy children in at-risk for atopic disease/Experiment 1
• Distinct distal gut microbiome diversity and composition in healthy children from Bangladesh and the United States/Experiment 1
• Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study/Experiment 1
• Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease/Experiment 1
• Correlation between body mass index and gut concentrations of Lactobacillus reuteri, Bifidobacterium animalis, Methanobrevibacter smithii and Escherichia coli/Experiment 1
• Comparison of the respiratory microbiome in healthy nonsmokers and smokers/Experiment 1
• Human intestinal microbiota composition is associated with local and systemic inflammation in obesity/Experiment 1
• Decreased dietary fiber intake and structural alteration of gut microbiota in patients with advanced colorectal adenoma/Experiment 1
• Effects of amoxicillin treatment on the salivary microbiota in children with acute otitis media/Experiment 1
• Investigation of the effect of type 2 diabetes mellitus on subgingival plaque microbiota by high-throughput 16S rDNA pyrosequencing/Experiment 1
• Differences in gut microbiota composition between obese and lean children: a cross-sectional study/Experiment 1
• Environmental particulate matter induces murine intestinal inflammatory responses and alters the gut microbiome/Experiment 1
• Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort/Experiment 1
• Gut microbiota composition in male rat models under different nutritional status and physical activity and its association with serum leptin and ghrelin levels/Experiment 1
• Dysbiosis signature of fecal microbiota in colorectal cancer patients/Experiment 1
• Comparison of the vaginal microbiota diversity of women with and without human papillomavirus infection: a cross-sectional study/Experiment 1
• High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients/Experiment 1
• Oral bacterial community dynamics in paediatric patients with malignancies in relation to chemotherapy-related oral mucositis: a prospective study/Experiment 1
• Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children/Experiment 1
• Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults/Experiment 1
• Human gut microbiota changes reveal the progression of glucose intolerance/Experiment 1
• Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis/Experiment 1
• Diversified microbiota of meconium is affected by maternal diabetes status/Experiment 1
• Diverse vaginal microbiomes in reproductive-age women with vulvovaginal candidiasis/Experiment 1
• Oral status in patients with early rheumatoid arthritis: a prospective, case-control study/Experiment 1
• Microbial enterotypes, inferred by the prevotella-to-bacteroides ratio, remained stable during a 6-month randomized controlled diet intervention with the new nordic diet/Experiment 1
• Human gut microbiome and risk for colorectal cancer/Experiment 1
• Changes of saliva microbiota in nasopharyngeal carcinoma patients under chemoradiation therapy/Experiment 1
• An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia/Experiment 1
• 16S rRNA gene pyrosequencing reveals shift in patient faecal microbiota during high-dose chemotherapy as conditioning regimen for bone marrow transplantation/Experiment 1
• Microbial dysbiosis is associated with human breast cancer/Experiment 1
• Fecal microbiota imbalance in Mexican children with type 1 diabetes/Experiment 1
• HIV Infection is associated with compositional and functional shifts in the rectal mucosal microbiota/Experiment 1
• Altered fecal microbiota composition associated with food allergy in infants/Experiment 1
• Meconium microbiome analysis identifies bacteria correlated with premature birth/Experiment 1
• The treatment-naive microbiome in new-onset Crohn's disease/Experiment 1
• Short-term effect of antibiotics on human gut microbiota/Experiment 1
• The impact of postnatal antibiotics on the preterm intestinal microbiome/Experiment 1
• Dynamic microbe and molecule networks in a mouse model of colitis-associated colorectal cancer/Experiment 1
• The subgingival microbiome of clinically healthy current and never smokers/Experiment 1
• Efficacy of fecal microbiota transplantation in 2 children with recurrent Clostridium difficile infection and its impact on their growth and gut microbiome/Experiment 1
• Effect of metformin on metabolic improvement and gut microbiota/Experiment 1
• Differences in gastric mucosal microbiota profiling in patients with chronic gastritis, intestinal metaplasia, and gastric cancer using pyrosequencing methods/Experiment 1
• Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection/Experiment 1
• The semen microbiome and its relationship with local immunology and viral load in HIV infection/Experiment 1
• The human gut microbiome as a screening tool for colorectal cancer/Experiment 1
• Microbiota in the Throat and Risk Factors for Laryngeal Carcinoma/Experiment 1
• Alcohol and tobacco consumption affects bacterial richness in oral cavity mucosa biofilms/Experiment 1
• Subgingival microbiome in smokers and non-smokers in Korean chronic periodontitis patients/Experiment 1
• Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease/Experiment 1
• Potential of fecal microbiota for early-stage detection of colorectal cancer/Experiment 1
• Intestinal microbiota development in preterm neonates and effect of perinatal antibiotics/Experiment 1
• Gut microbiota are related to Parkinson's disease and clinical phenotype/Experiment 1
• The conjunctival microbiome in health and trachomatous disease: a case control study/Experiment 1
• Microbiome changes in healthy volunteers treated with GSK1322322, a novel antibiotic targeting bacterial peptide deformylase/Experiment 1
• The gut microbiota of Colombians differs from that of Americans, Europeans and Asians/Experiment 1
• Infant gut microbiota and food sensitization: associations in the first year of life/Experiment 1
• Collateral damage from oral ciprofloxacin versus nitrofurantoin in outpatients with urinary tract infections: a culture-free analysis of gut microbiota/Experiment 1
• Characterization of the gut microbiota of Papua New Guineans using reverse transcription quantitative PCR/Experiment 1
• Microbiota disbiosis is associated with colorectal cancer/Experiment 1
• Effects of surgical and dietary weight loss therapy for obesity on gut microbiota composition and nutrient absorption/Experiment 1
• Gut microbiome development along the colorectal adenoma-carcinoma sequence/Experiment 1
• Study of the diversity and short-chain fatty acids production by the bacterial community in overweight and obese Mexican children/Experiment 1
• 16S gut community of the Cameron County Hispanic Cohort/Experiment 1
• Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease/Experiment 1
• Metagenomic analysis of the impact of nitrofurantoin treatment on the human faecal microbiota/Experiment 1
• Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis/Experiment 1
• Altered fecal microbiota composition in patients with major depressive disorder/Experiment 1
• Gut microbiota trajectory in pediatric patients undergoing hematopoietic SCT/Experiment 1
• Determining the Long-term Effect of Antibiotic Administration on the Human Normal Intestinal Microbiota Using Culture and Pyrosequencing Methods/Experiment 1
• Gut microbiome and innate immune response patterns in IgE-associated eczema/Experiment 1
• Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes/Experiment 1
• Prevalent high-risk HPV infection and vaginal microbiota in Nigerian women/Experiment 1
• Chemotherapy-driven dysbiosis in the intestinal microbiome/Experiment 1
• Dysbiosis of upper respiratory tract microbiota in elderly pneumonia patients/Experiment 1
• Virulence genes are a signature of the microbiome in the colorectal tumor microenvironment/Experiment 1
• Colonic bacterial composition in Parkinson's disease/Experiment 1
• Fusobacterium nucleatum and T Cells in Colorectal Carcinoma/Experiment 1
• Obesity Alters the Microbial Community Profile in Korean Adolescents/Experiment 1
• Influence of Intrapartum Antibiotic Prophylaxis for Group B Streptococcus on Gut Microbiota in the First Month of Life/Experiment 1
• Probiotics modify human intestinal mucosa-associated microbiota in patients with colorectal cancer/Experiment 1
• Reduced Levels of D-dimer and Changes in Gut Microbiota Composition After Probiotic Intervention in HIV-Infected Individuals on Stable ART/Experiment 1
• Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing/Experiment 1
• Integrating microbial and host transcriptomics to characterize asthma-associated microbial communities/Experiment 1
• The stool microbiota of insulin resistant women with recent gestational diabetes, a high risk group for type 2 diabetes/Experiment 1
• Fecal Microbiota Characteristics of Patients with Colorectal Adenoma Detected by Screening: A Population-based Study/Experiment 1
• Effect of ethnicity and socioeconomic variation to the gut microbiota composition among pre-adolescent in Malaysia/Experiment 1
• Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters/Experiment 1
• Lactobacillus rhamnosus GG-supplemented formula expands butyrate-producing bacterial strains in food allergic infants/Experiment 1
• Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment/Experiment 1
• Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer/Experiment 1
• High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome/Experiment 1
• The Intestinal Microbiota in Acute Anorexia Nervosa and During Renourishment: Relationship to Depression, Anxiety, and Eating Disorder Psychopathology/Experiment 1
• Faecalibacterium prausnitzii subspecies-level dysbiosis in the human gut microbiome underlying atopic dermatitis/Experiment 1
• Variations of Tongue Coating Microbiota in Patients with Gastric Cancer/Experiment 1
• Gut mucosal microbiome across stages of colorectal carcinogenesis/Experiment 1
• Correlation between body mass index and faecal microbiota from children/Experiment 1
• Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversity/Experiment 1
• The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota/Experiment 1
• Decreased Diversity of the Oral Microbiota of Patients with Hepatitis B Virus-Induced Chronic Liver Disease: A Pilot Project/Experiment 1
• Oral Microbiota and Risk for Esophageal Squamous Cell Carcinoma in a High-Risk Area of China/Experiment 1
• Alterations in the gut microbiotas of children with food sensitization in early life/Experiment 1
• Gut Dysbiosis in Patients with Anorexia Nervosa/Experiment 1
• Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)/Experiment 1
• Different gastric microbiota compositions in two human populations with high and low gastric cancer risk in Colombia/Experiment 1
• The Gut Microbiome Is Altered in a Letrozole-Induced Mouse Model of Polycystic Ovary Syndrome/Experiment 1
• Gut Microbiota and Metabolic Endotoxemia in Young Obese Mexican Subjects/Experiment 1
• Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease/Experiment 1
• Lower Neighborhood Socioeconomic Status Associated with Reduced Diversity of the Colonic Microbiota in Healthy Adults/Experiment 1
• Molecular detection of intrauterine microbial colonization in women with endometriosis/Experiment 1
• Characterization of the Gut Microbial Community of Obese Patients Following a Weight-Loss Intervention Using Whole Metagenome Shotgun Sequencing/Experiment 1
• Cervical Microbiota Associated with Higher Grade Cervical Intraepithelial Neoplasia in Women Infected with High-Risk Human Papillomaviruses/Experiment 1
• Microbiome Survey of the Inflamed and Noninflamed Gut at Different Compartments Within the Gastrointestinal Tract of Inflammatory Bowel Disease Patients/Experiment 1
• Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome/Experiment 1
• The microbiome of the oral mucosa in irritable bowel syndrome/Experiment 1
• Evaluation of the effects of intrapartum antibiotic prophylaxis on newborn intestinal microbiota using a sequencing approach targeted to multi hypervariable 16S rDNA regions/Experiment 1
• Gut Microbiota Differences in Children From Distinct Socioeconomic Levels Living in the Same Urban Area in Brazil/Experiment 1
• Tumour-associated and non-tumour-associated microbiota in colorectal cancer/Experiment 1
• Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid/Experiment 1
• Relative Abundance in Bacterial and Fungal Gut Microbes in Obese Children: A Case Control Study/Experiment 1
• Cigarette smoking and the oral microbiome in a large study of American adults/Experiment 1
• Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations/Experiment 1
• Changes in the salivary microbiota of oral leukoplakia and oral cancer/Experiment 1
• The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin/Experiment 1
• An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis/Experiment 1
• Evidence for a distinct gut microbiome in kidney stone formers compared to non-stone formers/Experiment 1
• Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection/Experiment 1
• Colorectal Cancer and the Human Gut Microbiome: Reproducibility with Whole-Genome Shotgun Sequencing/Experiment 1
• Gut microbiota in early pediatric multiple sclerosis: a case-control study/Experiment 1
• Intestinal Microbiota Is Influenced by Gender and Body Mass Index/Experiment 1
• Weight gain in anorexia nervosa does not ameliorate the faecal microbiota, branched chain fatty acid profiles, and gastrointestinal complaints/Experiment 1
• Imbalance of Fecal Microbiota at Newly Diagnosed Type 1 Diabetes in Chinese Children/Experiment 1
• 16S rRNA amplicon sequencing identifies microbiota associated with oral cancer, human papilloma virus infection and surgical treatment/Experiment 1
• Sequencing of 16S rRNA reveals a distinct salivary microbiome signature in Behçet's disease/Experiment 1
• Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder/Experiment 1
• Early-life gut microbiome composition and milk allergy resolution/Experiment 1
• Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota/Experiment 1
• Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome/Experiment 1
• Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls/Experiment 1
• Alterations of the human gut microbiome in multiple sclerosis/Experiment 1
• Early-Life Events, Including Mode of Delivery and Type of Feeding, Siblings and Gender, Shape the Developing Gut Microbiota/Experiment 1
• Microbial Community of Healthy Thai Vegetarians and Non-Vegetarians, Their Core Gut Microbiota, and Pathogen Risk/Experiment 1
• Effects of Gut Microbiota Manipulation by Antibiotics on Host Metabolism in Obese Humans: A Randomized Double-Blind Placebo-Controlled Trial/Experiment 1
• Pediatric obesity is associated with an altered gut microbiota and discordant shifts in Firmicutes populations/Experiment 1
• The skin microbiome is different in pediatric versus adult atopic dermatitis/Experiment 1
• Alterations in the Fecal Microbiota of Patients with HIV-1 Infection: An Observational Study in A Chinese Population/Experiment 1
• Comparison of the gut microbial community between obese and lean peoples using 16S gene sequencing in a Japanese population/Experiment 1
• The early infant gut microbiome varies in association with a maternal high-fat diet/Experiment 1
• Gastrointestinal microbial populations can distinguish pediatric and adolescent Acute Lymphoblastic Leukemia (ALL) at the time of disease diagnosis/Experiment 1
• Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis/Experiment 1
• Joint effects of pregnancy, sociocultural, and environmental factors on early life gut microbiome structure and diversity/Experiment 1
• Whole metagenome profiling reveals skin microbiome-dependent susceptibility to atopic dermatitis flare/Experiment 1
• Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls/Experiment 1
• Skin microbiome before development of atopic dermatitis: Early colonization with commensal staphylococci at 2 months is associated with a lower risk of atopic dermatitis at 1 year/Experiment 1
• Gut microbiome alterations in patients with stage 4 hepatitis C/Experiment 1
• Shifts in Lachnospira and Clostridium sp. in the 3-month stool microbiome are associated with preschool age asthma/Experiment 1
• Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study/Experiment 1
• Shifts in the Fecal Microbiota Associated with Adenomatous Polyps/Experiment 1
• Prevotella and Klebsiella proportions in fecal microbial communities are potential characteristic parameters for patients with major depressive disorder/Experiment 1